# Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation

> **NCT06212674** · PHASE4 · RECRUITING · sponsor: **Medical University of Silesia** · enrollment: 240 (estimated)

## Conditions studied

- Ischemic Stroke
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** PVI + LAAO, single stage
- **PROCEDURE:** LAAO
- **DRUG:** NOAC

## Key facts

- **NCT ID:** NCT06212674
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2027-10-31
- **Final completion:** 2030-10-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212674, "Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06212674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*